Title: Bioenergetika imunitnho systmu a imunosupresivn mechanismy APCs
1Bioenergetika imunitního systému a
imunosupresivní mechanismy APCs
- Pokroky v imunologii
- Brezen 2006
- Karel Drbal
2Cellular energy metabolism
- ATP is the principal immediate donor of free
energy. Turnover is very high an ATP molecule is
typically consumed within a minute of its
formation
Buttgereit ImmunolToday 21192
3Energy supply and immune functions (examples)
- Energy deficit in Late stages of septic and
haemorrhagic shock inflammation is followed by
marked immunosuppression of T cells - increased mitochondrial deficit with ageing gt
loss of T cell function - apoptosis x necrosis x autophagy type of cell
death might be determined by the intensity and
duration of cell damage and ATP absence/presence
Buttgereit ImmunolToday 21192
4Energy supply and immune functions (2)
5Growth factors costimulation regulate nutrient
uptake
- The mitogenic stimulation of thymocytes or naive
T cells induces an almost 20-fold increase in
glucose uptake within 1 hour (glucose catabolism
required for cell cycle entry)
METABOLIC SWITCH
OXIDATIVE PHOSPHORYLATION
only for survival
6T cell quiescence
- Self-maintenance of quiescent T cells is a highly
regulated and energetically demanding process. - Quiescence is maintained, in part, by regulated
protein turnover, which consumes a large amount
of ATP. - survival-promoting cytokines induce transcription
factors to maintain actively the expression of
inhibitors of the genes that are involved in
cellular activation (IkB) - family of E3 UBIQUITIN LIGASES functions to
maintain peripheral T cells, by potentiating the
rapid degradation of protein kinases such as
those that are activated by antigen- or
cytokine-receptor ligation
7Terms
- GLYCOLYSIS
- A metabolic process that occurs in the cytosol
and breaks down one molecule of glucose into two
molecules of pyruvate, resulting in the
production of ATP. Pyruvate is converted to
lactate, which regenerates the NAD that is
required as an electron acceptor in this
catabolic process. Alternatively, pyruvate can be
oxidized in the tricarboxylic-acid cycle, and NAD
can be regenerated in one of two mitochondrial
shuttles that end with electron donation to the
electron-transport chain. - OXIDATIVE PHOSPHORYLATION
- A metabolic process that encompasses two sets of
reactions. The first reaction involves the
conversion of intermediate molecules (pyruvate
and fatty acids) to acetyl coenzyme A
(acetyl-CoA) and the degradation of acetyl-CoA to
carbon dioxide in the tricarboxylic-acid cycle,
yielding free electrons that are carried by NADH
and FADH2. The second reaction involves the
transfer of electrons from NADH and FADH2 to the
electron-transport chain, resulting in the
movement of protons out of the mitochondrial
matrix. The resulting electrochemical potential
is used by the F1F0 ATP synthase to synthesize
ATP. - CATABOLIC METABOLISM
- The breakdown of complex substances into simpler
ones. This often allows cells to capture the
released reduction equivalents and channel them
into ATP production. Examples include the
oxidation of fatty acids and amino acids. - ANABOLIC METABOLISM
- The synthesis of complex macromolecules from
simpler intermediates at the expense of ATP.
Examples include the synthesis of nucleotides
from ribose-5-phosphate, lipids from acetyl
coenzyme A, and proteins from amino acids. - AEROBIC GLYCOLYSIS
- A metabolic process that is preferentially
induced in proliferating lymphocytes and is also
characteristic of neoplastic and transformed
cells. In contrast to anaerobic conditions (such
as in skeletal muscle and inflamed tissues), in
which glycolysis is the main source of ATP,
lymphocytes in the peripheral blood are not
exposed to low oxygen concentrations however,
they continue to excrete excess pyruvate as
lactate rather than fully oxidizing it in the
tricarboxylic-acid cycle.
8The PI3K pathway regulates energy metabolism
- Stimuli
- cytokines (both PI3K and JAK pathways)
- costimulation - CD28/CTLA4-B7 (mainly PI3K
pathway) - Genes involved in coordination of catabolic and
anabolic metabolism - TSC1 (tuberous sclerosis1), TSC2,
- RHEB (RAS homologue enriched in brain),
- RICTOR (rapamycin-insensitive companion of TOR)
- RAPTOR (regulatory associated protein of TOR),
- PTEN (phosphatase and tensin homologue) and
- PP2A (protein phosphatase 2A)
- and the core kinases of this pathway AKT/PKB,
AMPK, PIM2 and TOR.
9Inhibition of the PI3K pathway by rapamycin
- potent inhibitor of energy metabolism
- G1 arrest
- suppresses cap-dependent translation
- stimulus- or cell-type specific
- selective accumulation of CD4CD25 regulatory T
cells - does not phenocopy the effects of growth-factor
or nutrient deprivation - alternative pathway of metabolism regulation
- JAK induced expression of PIM1, PIM2 oncogenic
kinases - immunotherapeutics
- patients with autoimmune or infectious diseases
or for those who are undergoing solid-organ
transplantation
10Effects of other drugs on cellular metabolism
- Glucocorticoids (major side-effects !)
- Lazaroids (free radical scavengers and membrane
stabilizers) - Cyclosporine A and FK506 (cyclophilin-targeted
immunosuppressants) - Channel blockers - promising! (voltage-gated K
channel Kv1.3, Ca2-activated (KCa) channels)
11APCs regulate uptake of essential amino acids in
T cells
- Cysteine redox regulation of cysteine membrane
transport - APCs regulate T-cell proliferation by controlling
the availability of the amino acid cysteine,
which is present only at a low concentration in
blood plasma (intracellular reduced cysteine and
extracellular oxidized di-cystine equilibrium is
defined by redox conditions both inside and
outside the cell) but lymphocytes lack specific
cystine transporters and cannot synthesize
cysteine. The activation of dendritic cells or
macrophages by ligation of CD40 or by treatment
with LPS or TNF increases cystine uptake and
cysteine production by these cells, and it also
promotes the secretion of thioredoxin, which
reduces extracellular cystine to cysteine,
thereby making cysteine available to nearby
lymphocytes. - Tryptophan catabolism (deprivation toxic
metabolites) - APCs can also control the T-cell response by
regulating the extracellular concentration of
tryptophan. Tryptophan is enzymatically degraded
by indoleamine 2,3-dioxygenase (IDO), which is
expressed at high concentrations in placenta and
potentiates fetal tolerance during embryonic
development. Induction of IDO activity in
macrophages depletes extracellular tryptophan,
and tryptophan metabolites can suppress the
immune response by inducing either T-cell death,
through the generation of reactive oxygen
species, or T-cell anergy, by activating the
stress responsive kinase GCN2. Macrophages
themselves escape growth limitation that is
caused by tryptophan catabolism, in part, by
upregulating expression of tryptophanyl tRNA
synthetase. - Arginine catabolism (deprivation toxic
metabolites) - increased metabolism of L-arginine by myeloid
cells can result in the impairment of lymphocyte
responses to antigen during immune responses and
tumour growth - arginase and nitric-oxide synthase (use
L-arginine as substrate) are crucial components
of this lymphocyte-suppression pathway
12Overview of IDO/tryptophan pathways
13Myeloid suppressor cells-T cell relationship (IDO)
- Myeloid cell differentiation Pro-inflammatory
signals (such as CD40 ligand, TNF, LPS)
versusTolerogenic signals (such as
CTLA4CD80/CD86 ligation by regulatory T cells) - Production of major anti-inflammatory T cell
suppressive mediators - prostaglandin E2, eicosanoids and cytokines
(IL-10, TGFb) - Reactive free radicals (ROS, RNOS) are also
suppressive for T cells - Novel mechanism of essential AA deprivation by
IDO (indoleamine 2,3 dioxygenase), ARG (arginase)
and NOS (nitric oxide synthase) - ancient antibacterial mechanisms where
macrophages inhibit microbial infections by
producing IDO, which catabolizes tryptophan
for single-celled organisms, nutrient depletion
is a common biological strategy to control
proliferation of competing cells (also iron
chelator lactoferrin) - local veto for T cell response tolerance
induction at feto-maternal barrier (IDO
expression in placenta) - IFNg , regulatory T cells CTLA4 gt induced Mf IDO
expression - treatment with 1-methyl-tryptophan (a
pharmacological inhibitor of IDO) induced rapid
and uniform rejection of allogeneic conceptus a
few days after implantation. - T cell has a cell-cycle regulatory checkpoint for
available free tryptophan
14Mutual NOS-IDO regulation
- inflammation (IFNg) induced NO synthetase (iNOS)
produce NO which inhibits IDO activity - binds to the heme complex of IDO
- some tryptophan metabolites inhibit iNOS activity
- iNOS and IDO gene expression is coordinated by
proinflammatory cytokines - Tryptophan-tRNA synthetase is the only tRNA
synthetase gene inducible by IFNg - allows cells that produce IDO to access lower
tryptophan concentrations during inflammation in
order to survive. - ? is there a special reason why tryptophan
catabolism might be used to regulate T-cell
proliferation? - tryptophan is the most energetically expensive
amino acid to synthesize.
15IDO regulate immune response
- chronic infection
- chronic lentiviral infection (HIV) occur despite
initially potent antiviral T-cell responses. - chronic inflammation
- provoke sustained IDO production
- autoimmunity
- the only amino acid whose metabolism has been
linked with autoimmunity - cancer
- tumor-resident macrophages suppress infiltrated T
cells (similar to placenta)
16L-arginine overview
- conditionally essential AA
- metabolized by the enzymes ARG (arginase)
producing urea and L-ornithine and iNOS
(inducible nitric oxide synthase) which give rise
to nitric oxide (NO) and L-citrulline
17L-arginine T cell suppression-ARG
- ARG dependent
- MSC consumed l-arginine from the extracellular
environment, and they inhibited re-expression of
the ?-chain of CD3 after its TCR-signalling-induce
d internalization - amino-acid loss and urea have been shown to alter
the translation of various mRNAs in other cell
types, through the kinase pathways that involve
general control non-depressible 2 (GCN2) and
mammalian target of rapamycin (mTOR)
18L-arginine T cell suppression-iNOS
- NOS dependent
- NO is known to negatively regulate
intracellular-signalling proteins either
directly, by S-nitrosylation of crucial cysteine
residues, or indirectly, by activation of soluble
guanylate cyclase and cyclic-GMP-dependent
protein kinase - block cytokine-JAK-STAT pathway
- production of reactive free radicals
19L-arginine T cell suppression
- NOS ARG dependent
- radicals (ROS, RNOS)!!! (most potent
peroxynitrite ONOO-) - induction of T cell death
20ROS, RNOS
- REACTIVE OXYGEN SPECIES (ROS). Aerobic organisms
derive their energy from the reduction of oxygen
(O2). The metabolism of O2, and in particular its
reduction through the mitochondrial
electrontransfer chain, generates by-products
such as superoxide (O2), hydrogen peroxide
(H2O2) and hydroxyl radicals (OH). These three
species and the unstable intermediates that are
formed by lipid peroxidation are referred to as
ROS. ROS can damage important intracellular
targets, such as DNA, carbohydrates or proteins. - REACTIVE NITROGEN OXIDE SPECIES (RNOS). Nitric
oxide (NO) chemistry is complex because of the
extreme reactivity of NO, which can result in the
formation of different reactive nitrogen
intermediates (RNI) depending on the amount of NO
that is produced by cells. At low concentrations,
NO reacts directly with metals and radicals. At
higher concentrations, indirect effects prevail,
and these include several oxidation or
nitrosylation reactions with oxygen (O2) that
result in the production of various moieties. NO
and related RNI are effective antimicrobial
agents and signal-transducing molecules. The term
RNOS, although less frequently used, more
specifically indicates this family of molecules
than does the term RNI.
21(No Transcript)
22Prednáka a clánky dostupné na
- http//www.img.cas.cz/mi/prednasky/